Nifty
:
23907.25
Sensex
:
79117.11
557.35 (2.39%)
1961.32 (2.54%)
Nifty
Sensex
:
:
23907.25
79117.11
557.35 (2.39%)
1961.32 (2.54%)

Ind-Swift Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 532305 | NSE: INDSWFTLAB

NSE BSE
133.33
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  127.50
  •  134.99
  •  127.37
  •  127.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  969740
  •  1281.51
  •  186.00
  •  89.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 601.80
  • 2.31
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 179.74
  • N/A
  • 0.59

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.00%
  • 16.50%
  • 36.63%
  • FII
  • DII
  • Others
  • 0.65%
  • 0.00%
  • 4.22%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.85
  • 10.44
  • 7.24

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.10
  • 12.12
  • 5.38

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.64
  • 3.87
  • 11.03

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.87
  • 0.87
  • 0.93

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.72
  • 5.91
  • 4.93

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
11.96
289.71
-95.87%
33.17
310.34
-89.31%
393.33
304.25
29.28%
287.51
312.69
-8.05%
Expenses
23.75
224.02
-89.40%
42.91
250.04
-82.84%
430.64
240.57
79.01%
235.82
258.92
-8.92%
EBITDA
-11.80
65.69
-
-9.74
60.30
-
-37.30
63.67
-
51.69
53.76
-3.85%
EBIDTM
-98.65%
22.68%
-29.37%
19.43%
-9.48%
20.93%
17.98%
17.19%
Other Income
13.01
7.40
75.81%
11.14
5.61
98.57%
25.25
10.21
147.31%
7.11
8.36
-14.95%
Interest
0.41
21.14
-98.06%
0.17
20.38
-99.17%
-11.47
21.82
-
21.05
22.38
-5.94%
Depreciation
0.22
13.19
-98.33%
0.25
13.88
-98.20%
12.67
9.29
36.38%
13.56
15.39
-11.89%
PBT
0.58
38.77
-98.50%
0.98
31.64
-96.90%
373.34
16.13
2,214.57%
24.19
24.35
-0.66%
Tax
0.18
6.93
-97.40%
-0.03
14.24
-
134.47
41.17
226.62%
4.67
-3.27
-
PAT
0.40
31.83
-98.74%
1.01
17.40
-94.20%
238.87
-25.05
-
19.53
27.62
-29.29%
PATM
3.34%
10.99%
3.04%
5.61%
60.73%
-8.23%
6.79%
8.83%
EPS
0.07
5.36
-98.69%
0.16
2.92
-94.52%
40.42
-4.25
-
3.29
4.65
-29.25%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
725.97
1,280.90
1,207.31
1,038.73
891.34
779.64
756.60
762.52
697.42
653.25
660.45
Net Sales Growth
-40.35%
6.10%
16.23%
16.54%
14.33%
3.05%
-0.78%
9.33%
6.76%
-1.09%
 
Cost Of Goods Sold
460.23
661.46
655.59
537.43
451.44
396.66
403.36
390.56
392.19
353.01
407.39
Gross Profit
265.74
619.44
551.73
501.30
439.90
382.98
353.24
371.96
305.24
300.23
253.07
GP Margin
36.60%
48.36%
45.70%
48.26%
49.35%
49.12%
46.69%
48.78%
43.77%
45.96%
38.32%
Total Expenditure
733.12
1,026.69
978.11
843.11
708.54
636.16
630.48
628.43
591.47
545.97
571.69
Power & Fuel Cost
-
61.43
76.07
58.45
37.31
34.65
37.44
29.58
26.00
22.65
34.78
% Of Sales
-
4.80%
6.30%
5.63%
4.19%
4.44%
4.95%
3.88%
3.73%
3.47%
5.27%
Employee Cost
-
141.52
126.17
117.40
97.86
95.92
90.98
88.12
69.65
62.76
50.65
% Of Sales
-
11.05%
10.45%
11.30%
10.98%
12.30%
12.02%
11.56%
9.99%
9.61%
7.67%
Manufacturing Exp.
-
45.50
43.41
40.85
64.24
59.30
50.06
63.50
43.40
38.56
30.13
% Of Sales
-
3.55%
3.60%
3.93%
7.21%
7.61%
6.62%
8.33%
6.22%
5.90%
4.56%
General & Admin Exp.
-
55.12
38.17
36.03
27.17
27.58
27.27
28.69
23.33
21.54
20.33
% Of Sales
-
4.30%
3.16%
3.47%
3.05%
3.54%
3.60%
3.76%
3.35%
3.30%
3.08%
Selling & Distn. Exp.
-
38.68
37.29
39.03
28.74
21.65
21.30
27.92
29.06
28.87
28.33
% Of Sales
-
3.02%
3.09%
3.76%
3.22%
2.78%
2.82%
3.66%
4.17%
4.42%
4.29%
Miscellaneous Exp.
-
22.98
1.42
13.93
1.77
0.40
0.07
0.06
7.86
18.57
28.33
% Of Sales
-
1.79%
0.12%
1.34%
0.20%
0.05%
0.01%
0.01%
1.13%
2.84%
0.01%
EBITDA
-7.15
254.21
229.20
195.62
182.80
143.48
126.12
134.09
105.95
107.28
88.76
EBITDA Margin
-0.98%
19.85%
18.98%
18.83%
20.51%
18.40%
16.67%
17.59%
15.19%
16.42%
13.44%
Other Income
56.51
45.37
33.50
43.50
22.71
33.46
36.91
25.82
22.62
15.91
22.25
Interest
10.16
51.10
92.17
95.55
100.22
106.65
92.24
35.38
90.27
106.42
117.29
Depreciation
26.70
53.30
57.36
131.04
87.29
90.06
104.05
86.62
88.26
84.75
84.29
PBT
399.09
195.17
113.17
12.53
18.01
-19.77
-33.26
37.92
-49.96
-67.98
-90.56
Tax
139.29
160.31
38.69
14.68
21.16
1.42
20.73
14.01
-16.17
-24.09
-23.98
Tax Rate
34.90%
27.56%
44.72%
117.16%
117.49%
-7.18%
41.73%
38.94%
29.24%
29.10%
16.73%
PAT
259.81
421.45
47.83
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
-119.37
PAT before Minority Interest
259.81
421.45
47.83
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
-119.37
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
35.79%
32.90%
3.96%
-0.21%
-0.35%
-2.72%
3.83%
2.88%
-5.61%
-8.98%
-18.07%
PAT Growth
401.56%
781.14%
-
-
-
-
31.71%
-
-
-
 
EPS
43.96
71.31
8.09
-0.36
-0.53
-3.59
4.90
3.72
-6.62
-9.93
-20.20

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
931.46
681.93
600.97
603.51
640.64
587.81
553.24
531.32
517.43
594.85
Share Capital
59.09
59.81
59.81
59.81
59.81
48.29
46.00
45.46
41.68
41.68
Total Reserves
872.37
622.12
541.17
543.70
580.83
539.53
505.69
483.39
475.74
553.17
Non-Current Liabilities
-19.46
741.18
813.57
840.15
828.33
901.32
437.80
494.76
717.24
811.33
Secured Loans
11.16
752.60
847.78
884.13
885.96
953.86
503.97
563.69
666.84
723.03
Unsecured Loans
0.00
0.00
0.00
0.00
4.93
11.72
16.52
28.32
79.48
93.11
Long Term Provisions
1.23
17.79
17.03
15.73
14.76
14.34
13.32
9.16
0.00
0.00
Current Liabilities
221.28
371.09
334.47
314.52
323.07
356.00
935.93
1,005.02
950.81
832.82
Trade Payables
93.98
203.99
175.95
138.82
135.23
126.68
128.64
102.36
132.43
134.11
Other Current Liabilities
22.80
105.67
89.10
81.29
72.92
136.49
490.25
496.93
314.60
248.67
Short Term Borrowings
2.71
49.17
64.03
93.43
114.93
92.52
311.31
405.70
503.66
450.05
Short Term Provisions
101.79
12.25
5.39
0.98
0.00
0.31
5.73
0.03
0.12
0.00
Total Liabilities
1,133.26
1,794.20
1,748.90
1,758.09
1,792.04
1,845.13
1,926.97
2,031.10
2,185.48
2,239.00
Net Block
5.36
585.04
627.53
738.65
843.14
901.20
924.59
1,032.56
1,098.73
1,116.82
Gross Block
8.15
1,330.90
1,316.68
1,302.04
1,359.32
1,378.95
1,349.27
1,406.84
1,420.51
1,404.21
Accumulated Depreciation
2.79
745.86
689.15
563.38
516.18
477.75
424.68
374.28
321.78
287.40
Non Current Assets
472.13
629.68
673.56
813.91
929.00
1,009.05
1,087.71
1,202.46
1,263.78
1,319.18
Capital Work in Progress
0.00
7.71
10.31
18.84
11.45
19.87
68.60
70.26
78.47
112.83
Non Current Investment
110.54
30.34
29.06
35.53
17.45
31.03
31.02
31.09
17.63
17.52
Long Term Loans & Adv.
353.92
4.17
3.96
6.11
56.95
56.95
63.50
54.24
68.96
72.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
14.31
0.00
0.00
Current Assets
661.13
1,163.12
1,073.32
941.88
863.03
836.09
839.26
828.64
921.70
919.82
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
10.46
438.60
428.50
375.67
342.82
316.61
316.91
343.56
356.02
348.31
Sundry Debtors
169.12
505.32
454.78
432.39
396.45
350.85
407.76
357.27
372.45
389.04
Cash & Bank
431.93
18.20
21.48
11.60
10.58
29.97
9.45
16.13
22.58
19.84
Other Current Assets
49.62
9.02
16.92
56.33
113.18
138.66
105.14
111.69
170.66
162.64
Short Term Loans & Adv.
49.62
191.98
151.64
65.90
74.45
96.84
92.09
95.37
157.41
144.03
Net Current Assets
439.85
792.03
738.86
627.36
539.96
480.08
-96.67
-176.37
-29.11
87.01
Total Assets
1,133.26
1,792.80
1,746.88
1,755.79
1,792.03
1,845.14
1,926.97
2,031.10
2,185.48
2,239.00

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
-163.12
194.62
150.27
134.95
125.24
-64.40
73.09
95.57
79.43
98.40
PBT
195.17
113.17
12.53
18.01
-19.77
-33.26
37.87
-49.96
-67.98
-90.57
Adjustment
124.76
132.78
225.66
179.35
176.02
186.26
103.64
167.95
186.30
169.93
Changes in Working Capital
-483.05
-51.33
-87.92
-62.41
-31.01
-214.80
-68.41
-22.42
-38.89
22.87
Cash after chg. in Working capital
-163.12
194.62
150.27
134.95
125.24
-61.80
73.09
95.57
79.43
102.23
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
0.00
-2.60
0.00
0.00
0.00
-3.83
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-104.32
-13.37
4.77
-10.17
-9.10
-12.47
-17.40
-30.94
-29.56
-35.61
Net Fixed Assets
1,330.46
-12.32
-8.59
50.42
31.26
19.05
59.23
21.87
18.07
-34.69
Net Investments
-80.82
25.56
-55.35
-28.97
12.52
0.24
0.23
-12.97
-0.05
0.88
Others
-1,353.96
-26.61
68.71
-31.62
-52.88
-31.76
-76.86
-39.84
-47.58
-1.80
Cash from Financing Activity
680.71
-185.66
-140.88
-123.75
-133.26
99.62
-61.98
-68.90
-47.92
-63.72
Net Cash Inflow / Outflow
413.28
-4.41
14.17
1.03
-17.12
22.76
-6.30
-4.27
1.94
-0.94
Opening Cash & Equivalents
18.20
21.48
11.60
10.58
29.97
9.45
16.13
22.58
19.84
20.59
Closing Cash & Equivalent
431.93
18.20
25.77
11.61
10.58
29.97
9.45
16.13
21.78
19.84

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
157.64
84.25
68.33
66.35
70.21
73.01
65.58
58.08
56.78
67.21
ROA
28.79%
2.70%
-0.12%
-0.18%
-1.17%
1.53%
1.11%
-1.86%
-2.65%
-5.22%
ROE
58.97%
10.61%
-0.54%
-0.78%
-5.56%
8.99%
7.89%
-15.89%
-23.11%
-36.36%
ROCE
55.13%
13.25%
7.88%
8.31%
5.97%
9.25%
4.59%
2.19%
1.40%
-1.52%
Fixed Asset Turnover
1.93
0.92
0.80
0.67
0.57
0.56
0.56
0.51
0.48
0.48
Receivable days
95.44
144.51
154.46
168.41
174.12
182.19
181.25
185.94
206.44
223.20
Inventory Days
63.55
130.51
140.01
145.99
153.65
152.15
156.48
178.26
190.95
194.38
Payable days
82.21
105.77
106.89
110.78
68.85
63.73
60.79
64.19
12.73
29.95
Cash Conversion Cycle
76.78
169.25
187.58
203.62
258.91
270.60
276.94
300.00
384.67
387.63
Total Debt/Equity
0.01
1.71
2.33
2.56
2.48
3.21
4.38
4.77
6.25
5.12
Interest Cover
12.38
1.94
1.13
1.18
0.81
1.54
2.02
0.39
0.22
-0.22

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Ind-Swift Laboratories sets up new marketing office in New Delhi
    23rd Sep 2024, 11:19 AM

    The Delhi office is specifically designed to lead and drive marketing efforts for its Ethical Pharma Business and manage field sales force

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.